Stock Events

Stock Events

Genetic Technologies 

$1
23
+$0+0% Monday 00:00

Statistics

Day High
1
Day Low
1
52W High
1
52W Low
1
Volume
100
Avg. Volume
-
Mkt Cap
145.42M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

26FebExpected
Q4 2023
Q2 2024
Q4 2024
-0.03
0.3
0.63
0.97
Expected EPS
N/A
Actual EPS
N/A

Financials

-137.36%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
4.56MRevenue
-6.26MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GNTLF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Myriad Genetics
MYGN
Mkt Cap466.55M
Myriad Genetics offers genetic testing and precision medicine, directly competing in Genetic Technologies' market space.
Illumina
ILMN
Mkt Cap20.63B
Illumina provides sequencing and array-based solutions for genetic analysis, competing in the broader genomics industry.
Guardant Health
GH
Mkt Cap11.61B
Guardant Health specializes in liquid biopsies and cancer diagnostics, overlapping with Genetic Technologies' focus on genetic risk assessment.
Fulgent Genetics
FLGT
Mkt Cap407.57M
Fulgent Genetics provides comprehensive genetic testing, directly competing in the same space as Genetic Technologies.
Pacific Biosciences of California
PACB
Mkt Cap496.78M
Pacific Biosciences offers sequencing systems that compete in the broader market of genetic analysis and research.
Qiagen NV
QGEN
Mkt Cap7.06B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, and genetic research, competing in the genomics field.
Bionano Genomics
BNGO
Mkt Cap13.09M
Bionano Genomics focuses on genomic analysis, competing in the genetic testing and research market.
CRISPR Therapeutics
CRSP
Mkt Cap4.98B
CRISPR Therapeutics is involved in gene editing, a different approach but still competing in the broader genetic technologies and therapeutics market.

About

There is no Profile data available for DU8.SG.
Show more...
CEO
Mr. Kevin Camilleri
Employees
55
Country
Australia
ISIN
AU000000GTG7

Listings

STU
DE
DU8.STU
AU
AU
GTG.AU
F
DE
DU8.F
XNAS
US
GENE

0 Comments

Share your thoughts

FAQ

What is Genetic Technologies stock price today?▼
The current price of GNTLF is $1 USD — it has increased by +0% in the past 24 hours. Watch Genetic Technologies stock price performance more closely on the chart.
What is Genetic Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Genetic Technologies stocks are traded under the ticker GNTLF.
What is Genetic Technologies market cap?▼
Today Genetic Technologies has the market capitalization of 145.42M
What is Genetic Technologies revenue for the last year?▼
Genetic Technologies revenue for the last year amounts to 4.56M USD.
What is Genetic Technologies net income for the last year?▼
GNTLF net income for the last year is -6.26M USD.
How many employees does Genetic Technologies have?▼
As of May 06, 2026, the company has 55 employees.
In which sector is Genetic Technologies located?▼
Genetic Technologies operates in the Health & Wellness sector.
When did Genetic Technologies complete a stock split?▼
The last stock split for Genetic Technologies was on December 14, 2023 with a ratio of 1:100.
Where is Genetic Technologies headquartered?▼
Genetic Technologies is headquartered in Maroochydore, Australia.